Company intelligence / Profile preview

MLS Fund II

Ownership: Private
Development stage: Other

Overview

MLS Fund II, also known as Medical Life Science Fund II, is a venture capital fund focused on investments within the life sciences, biotechnology, and healthcare sectors. The fund typically targets early-to-mid-stage companies developing innovative therapeutics, medical devices, and diagnostic tools. By providing capital and strategic guidance, MLS Fund II aims to accelerate the development of breakthrough medical technologies and bring them to market. The fund is managed by experienced professionals with deep expertise in both the clinical and financial aspects of the healthcare industry.

Industry: Investors

Beyond the preview

Go deeper on MLS Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MLS Fund II.

Explore the full profile